Barcode No : 789749 Registration : 13/Apr/2025 12:13AM

Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM

Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 05:37AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : WHOLE BLOOD EDTA Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF HAEMATOLOGY
1.2
Test Description Observed Value Unit Reference Range

COMPLETE BLOOD COUNT+ESR (CBC+ESR)

HAEMOGLOBIN (Hb) 12.6 gm/dl 13.00-17.00

Colorimetric SLS
RED BLOOD CELLS- RBC COUNT 3.8 10^6/uL 4.50-5.50
Electrical Impedance
PACKED CELL VOLUME (PCV) -HEMATOCRIT 36.6 % 40-50
Calculated
MCV 96.1 fL 83-101
Calculated
MCH 32.9 pg 27-32
Calculated
MCHC 34.3 g/dl 32-36
Calculated
RED CELL DISTRIBUTION WIDTH (RDW-CV) 15.8 % 11.5-14.5
Whole blood EDTA,Flow Cytometry
RED CELL DISTRIBUTION WIDTH (RDW - SD) 51.3 fl 39.0-46.0
Whole Blood EDTA,Calculated
PLATELET COUNT 150 10^3/µL 150-410
Electrical Impedance
PLATELET DISTRIBUTION WIDTH (PDW) 17.4 fL 9.00-17.00
Whole Blood EDTA,Calculated
PCT(PLATELETCRIT) 0.16 % 0.108-0.282
Whole blood EDTA,Flow Cytometry
MEAN PLATELET VOLUME - MPV 12.4 fL 7.00-12.00
Calculated
P-LCR 43.2
P-LCC 56.00 % 30.0-90.0
Calculated
TOTAL LEUKOCYTE COUNT (TLC) 11.54 10^3/µL 4.5-10.0
Laser - Based Flow Cytometry / Microscopy
DIFFERENTIAL LEUKOCYTE COUNT

Page 1 of 14
Barcode No : 789749 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 05:37AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : WHOLE BLOOD EDTA Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF HAEMATOLOGY
1.2
Test Description Observed Value Unit Reference Range

Neutrophils 40.6 % 40-80

Laser - Based Flow Cytometry / Microscopy
Lymphocytes 50.3 % 20-40
Laser - Based Flow Cytometry / Microscopy
Eosinophils 3.0 % 1-6
Laser - Based Flow Cytometry / Microscopy
Monocytes 6.0 % 2-10
Laser - Based Flow Cytometry / Microscopy
Basophils 0.1 % 0.00-1.00
Whole blood EDTA,Flow Cytometry
ABSOLUTE NEUTROPHIL COUNT 4.69 10^3/µL 2.00-7.00
Whole Blood EDTA,Calculated
ABSOLUTE LYMPHOCYTE COUNT 5.8 10^3/µL 1.00-3.00
Calculated
ABSOLUTE EOSINOPHIL COUNT 0.35 10^3/µL 0.02-0.50
Calculated
ABSOLUTE MONOCYTE COUNT 0.69 10^3/µL 0.20-1.00
Calculated
ABSOLUTE BASOPHIL COUNT 0.01 10^3/µL 0.02-0.10
Calculated
ESR [WESTERGREN] 13.00 mm/1st 0-15
Sedimentation

INTERPRETATION:

A complete blood count (CBC), also known as a full blood count (FBC), is a set of medical laboratory tests that provide
information about the cells in a person's blood. The CBC indicates the counts of white blood cells, red blood cells and platelets,
the concentration of hemoglobin, and the hematocrit (the volume percentage of red blood cells). The red blood cell indices, which
indicate the average size and hemoglobin content of red blood cells, are also reported, and a white blood cell differential, which
counts the different types of white blood cells, may be included. The CBC is often carried out as part of a medical assessment and
can be used to monitor health or diagnose diseases. The results are interpreted by comparing them to reference ranges, which vary
with sex and age. Conditions like anemia and thrombocytopenia are defined by abnormal complete blood count results. The red
blood cell indices can provide information about the cause of a person's anemia such as iron deficiency and vitamin B12
deficiency, and the results of the white blood cell differential can help to diagnose viral, bacterial and parasitic infections and blood

Page 2 of 14
Barcode No : 789749 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 05:37AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : WHOLE BLOOD EDTA Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF HAEMATOLOGY
1.2
Test Description Observed Value Unit Reference Range

disorders like leukemia. Not all results falling outside of the reference range require medical intervention.

Page 3 of 14
Barcode No : 789750 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 05:29AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : SERUM Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF BIOCHEMISTRY
1.2
Test Description Observed Value Unit Reference Range

LIPID PROFILE

TOTAL CHOLESTEROL 155.06 mg/dl <200 Desirable~200 – 239

Cholesterol Oxidase,PAP Borderline >240 High Risk
TRIGLYCERIDES 170.25 mg/dL Normal : <161~High : 161 -
GPO-TRINDER 199~Hyper Triglyceridemic : 200
- 499~Very High : >499
H D L CHOLESTEROL 44 mg/dl >40 Recommended Range
Direct Enzymatic Colorimetric
L D L CHOLESTEROL 77.01 mg/dl 70-130
Calculated
VLDL 34.05 mg/dl 0.00-45.0
Spectrophotmetry/Calculated
T. CHOLESTEROL/ HDL RATIO 3.52 Ratio 3.40-4.40
Calculated
LDL / HDL RATIO 1.75 Ratio 1.0-3.5
Calculated
COMMENT :-
(#). A lipid panel measures five different types of lipids from a blood sample, including:
(1). Total cholesterol: This is your overall cholesterol level — the combination of LDL-C, VLDL-C and HDL-C.
(2). Low-density lipoprotein (LDL) cholesterol: This is the type of cholesterol that’s known as “bad cholesterol.” It can collect in your blood vessels and increase your
risk of cardiovascular disease.
(3). Very low-density lipoprotein (VLDL) cholesterol: This is a type of cholesterol that’s usually present in very low amounts when the
blood sample is a fasting samples since it’s mostly comes from food you’ve recently eaten. An increase in this type of cholesterol in a fasting sample may be a sign of
abnormal lipid metabolism.
(4). High-density lipoprotein (HDL) cholesterol: This is the type of cholesterol that’s known as “good cholesterol.” It helps decrease the buildup of LDL in your blood
vessels.
(5).Triglycerides: This is a type of fat from the food we eat. Excess amounts of triglycerides in your blood are associated with cardiovascular disease and pancreatic
inflammation.

Page 4 of 14
Barcode No : 789749 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 07:05AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : WHOLE BLOOD EDTA Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF BIOCHEMISTRY
1.2
Test Description Observed Value Unit Reference Range

HBA1C

HBA1c 6.2 %
HPLC
ESTIMATED AVG. GLUCOSE 131.24 mg/dl
Ref Range for HBA1c
Non-Diabetic :- 4.0 – 5.6
Increased Risk:- 5.7 – 6.4
In Diabetics:
Excellent Control: 6.5 – 7.0
Fair To Good Control: 7.0 – 8.0
Unsatisfactory Control:- 8.0 – 10
Poor Control: >10

COMMENT:
The Glycosylated Hemoglobin (HbA1c or A1c) test evaluates the average amount of glucose in the blood over the last 2 to 3 months.
This test is used to monitor treatment in someone who has been diagnosed with diabetes.
It helps to evaluate how well the person's glucose levels have been controlled by treatment over time. This test may be used to screen for and diagnose diabetes or risk of
developing diabetes.
Depending on the type of diabetes that a person has, how well their diabetes is controlled, and on doctor recommendations, the HbA1c test may be measured 2 to 4 times
each year.
The American Diabetes Association recommends HbA1c testing in diabetics at least twice a year.
When someone is first diagnosed with diabetes or if control is not good, HbA1c may be ordered more frequently.
Note: If a person has anemia, few type of hemoglobinopathy, hemolysis, or heavy bleeding, HbA1c test results may be falsely low.
If someone is iron-deficient, the HbA1c level may be increased.
If a person has had a recent blood transfusion, the HbA1c may be inaccurate and may not accurately reflect glucose control for 2 to 3 months.

Page 5 of 14
Barcode No : 789750 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 05:29AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : SERUM Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF BIOCHEMISTRY
1.2
Test Description Observed Value Unit Reference Range

KIDNEY FUNCTION TEST

SERUM UREA 27.48 mg/dL 19.0 - 45.0

Serum,Urease GLDH
SERUM CREATININE 0.85 mg/dL 0.7-1.30
Enzymatic
SERUM URIC ACID 6.2 mg/dL 3.5-7.2
Serum,Uricase
SERUM SODIUM 138.9 mmol/L 135-150
ISE, Direct
SERUM POTASSIUM 4.33 mmol/L 3.5-5.5
ISE, Direct
SERUM CHLORIDE 102.9 mmol/L 94-110
ISE, Direct
Blood Urea Nitrogen (BUN) 12.84 mg/dl 8.00-23.0
Calculated
UREA / CREATININE RATIO 32.33
CALCIUM 9.3 mg/dl 8.1-10.4

INTERPRETATION:

Normal range for a healthy person on normal diet: 12 - 20.

To Differentiate between pre- and postrenal azotemia.
INCREASED RATIO (>20:1) WITH NORMAL CREATININE:
[Link] azotemia (BUN rises without increase in creatinine) e.g. heart failure, salt depletion,dehydration, blood loss) due to
decreased glomerular filtration rate.
[Link] states with increased tissue breakdown.
[Link] hemorrhage.
[Link] protein intake.
[Link] renal function plus .
[Link] protein intake or production or tissue breakdown (e.g. infection, GI bleeding, thyrotoxicosis, Cushings syndrome, high

Page 6 of 14
Barcode No : 789750 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 05:29AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : SERUM Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF BIOCHEMISTRY
1.2
Test Description Observed Value Unit Reference Range

protein diet, burns,surgery, cachexia, high fever).

[Link] reabsorption (e.g. ureterocolostomy)
[Link] muscle mass (subnormal creatinine production)
[Link] drugs (e.g. tetracycline, glucocorticoids)
INCREASED RATIO (>20:1) WITH ELEVATED CREATININE LEVELS:
[Link] azotemia (BUN rises disproportionately more than creatinine) (e.g. obstructive uropathy).
[Link] azotemia superimposed on renal disease.
DECREASED RATIO (<10:1) WITH DECREASED BUN :
[Link] tubular necrosis.
[Link] protein diet and starvation.
[Link] liver disease.
[Link] causes of decreased urea synthesis.
[Link] dialysis (urea rather than creatinine diffuses out of extracellular fluid).
[Link] hyperammonemias (urea is virtually absent in blood).
[Link] (syndrome of inappropiate antidiuretic harmone) due to tubular secretion of urea.
[Link].
DECREASED RATIO (<10:1) WITH INCREASED CREATININE:
[Link] therapy (accelerates conversion of creatine to creatinine).
[Link] (releases muscle creatinine).
[Link] patients who develop renal failure.
INAPPROPIATE RATIO:
[Link] ketoacidosis (acetoacetate causes false increase in creatinine with certain methodologies,resulting in normal ratio when
dehydration should produce an increased BUN/creatinine ratio).
[Link] therapy (interferes with creatinine measurement).

Page 7 of 14
Barcode No : 789750 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 05:29AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : SERUM Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF BIOCHEMISTRY
1.2
Test Description Observed Value Unit Reference Range

EGFR (ESTIMATED GLOMERULAR FILTRATION RATE)

Estimated Glomerular Filtration Rate (eGFR) 103.60 mL/min/1.73m2 60-120

Calculated

INTERPRETATION:
AGE IN YEARS GFR IN mL/min/1.73m2
20-29 116
30-39 107
40-49 99
50-59 93
60-69 85
≥70 75

NOTE:

National Kidney Disease Education program recommends the use of MDRD equation to estimate or predict GFR in adults (≥20 years)

with Chronic Kidney Disease (CKD).

MDRD equation is most accurate for GFR ≤60 mL/min/1.73m2.

CKD stage Description GFR Associated findings

0 Normal kidney function >90 No proteinuria
1 Kidney damage with normal or high GFR >90 Presence of Protein, albumin,
cells or casts in urine
2 Mild decrease in GFR 60-89 -
3 Moderate decrease in GFR 30-59 -
4 Severe decrease in GFR 15-29 -
5 Kidney failure <15 -

Page 8 of 14
Barcode No : 789750 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 05:29AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : SERUM Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF BIOCHEMISTRY
1.2
Test Description Observed Value Unit Reference Range

IRON PROFILE -I

SERUM IRON LEVELS 52.90 ug/dl 65-175

Ferrozime
UIBC 312.20 ug/dL 110-370
NiTRO-PSAP
TOTAL IRON BINDING CAPACITY 365.1 ug/dl 240-450
Calculated
TRANSFERRIN SATURATION 14.49 % 20.0-50.0
Calculated

COMMENT:

Serum iron measures the amount of circulating iron that is bound to transferrin. Clinicians order this laboratory test when they are
concerned about iron deficiency, which can cause anemia and other problems. Total iron-binding capacity The test measures the
extent to which iron-binding sites in the serum can be saturated. Because the iron-binding sites in the serum are almost entirely
dependent on circulating transferrin, this is really an indirect measurement of the amount of transferrin in the blood. Taken together
with serum iron and percent transferrin saturation clinicians usually perform this test when they are concerned about anemia, iron
deficiency or iron deficiency anemia. However, because the liver produces transferrin, liver function must be considered when
performing this test. It can also be an indirect test of liver function, but is rarely used for this purpose.

LIVER FUNCTION TEST (PLUS)

TOTAL BILIRUBIN 1.58 mg/dL 0.10 - 1.2

Diazo
CONJUGATED ( D. Bilirubin) 0.41 mg/dL 0.0 - 0.30
Diazo
UNCONJUGATED ( I.D. Bilirubin) 1.17 mg/dl 0.0 - 1.0
Calculated
S.G.P.T 41.02 U/L 0-35
UV without P5P
SGOT 42.13 U/L 0-40
UV without P5P

Page 9 of 14
Barcode No : 789750 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 05:29AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : SERUM Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF BIOCHEMISTRY
1.2
Test Description Observed Value Unit Reference Range

ALKALINE PHOSPHATASE 109.60 U/L 53 - 128

AMP
TOTAL PROTEINS 6.8 g/dL 6.4 - 8.3
Biuret
ALBUMIN 3.6 g/dL 3.5 - 5.2
Bromocresol Green
GLOBULIN 3.2 g/dL 2.30-4.50
Calculated
A/G RATIO 1.13 1.0-2.3
Calculated
GGT 37 U/L 12.0-58.0
IFCC

INTERPRETATION
Bilirubin Elevated levels results from increased bilirubin production (eg hemolysis and ineffective erythropoiesis); decreased
bilirubin excretion (eg; obstruction and hepatitis); and abnormal bilirubin metabolism (eg; hereditary and neonatal jaundice).
Conjugated (direct) bilirubin is elevated more than unconjugated (indirect) bilirubin in viral hepatitis; drug reactions, alcoholic
liver disease conjugated (direct) bilirubin is also elevated more than unconjugated (indirect) bilirubin when there is some kind of
blockage of the bile ducts like in Gallstones getting into the bile ducts tumors & Scarring of the bile ducts.
Increased unconjugated (indirect) bilirubin may be a result of hemolytic or pernicious anemia, transfusion reaction & a common
metabolic condition termed Gilbert syndrome.
AST levels increase in viral hepatitis, blockage of the bile duct ,cirrhosis of the liver, liver cancer, kidney failure, hemolytic anemia,
pancreatitis, hemochromatosis. Ast levels may also increase after a heart attck or strenuous activity.
ALT is commonly measured as a part of a diagnostic evaluation of hepatocellular injury, to determine liver health.
GGT may be higher with diabetes, heart failure, hyperthyroidism, or pancreatitis. Higher GGT levels also may mean liver
damage from heavy, chronic alcohol abuse. GGT levels that are higher than normal may also signal a viral infection
Elevated ALP levels are seen in Biliary Obstruction, Osteoblastic Bone Tumors, Osteomalacia, Hepatitis, Hyperparathyriodism,
Leukemia, Lymphoma, paget`s disease, Rickets, Sarcoidosis etc. Elevated serum GGT activity can be found in diseases of the
liver, Biliary system and pancreas. Conditions that increase serum GGT are obstructive liver disease, high alcohol consumption and
use of enzyme-including drugs etc.
Serum total protein, in the plasma is made up of albumin and globulin. Higher-than-normal levels may be due to: Chronic
inflammation or infection, including HIV and hepatitis B or C, Multiple myeloma,Waldenstrom's disease. Lower-than-normal levels
may be due to: Agammaglobulinemia, Bleeding (hemorrhage), Burns, Glomerulonephritis, Liver disease, Malabsorption,

Page 10 of 14
Barcode No : 789750 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 05:29AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : SERUM Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF BIOCHEMISTRY
1.2
Test Description Observed Value Unit Reference Range

Malnutrition,

Page 11 of 14
Barcode No : 789752 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:12AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 04:52AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : URINE Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF CLINICAL PATHOLOGY

1.2
Test Description Observed Value Unit Reference Range

URINE ROUTINE EXAMINATION

QUANTITY 20 ML ml 0-50
visual
COLOUR PALE YELLOW PALE YELLOW
visual
TRANSPARENCY CLEAR Clear
visual
SPECIFIC GRAVITY 1.020 1.010 - 1.030
ION exchange
CHEMICAL EXAMINATION
PROTEIN NEGATIVE g/dL
Protein - error of Indicators
pH 5.5 5-7
Double Indicator
KETONE BODIES NEGATIVE NEGATIVE
Legals Nitroprasside
URINE GLUCOSE NEGATIVE
URINE FOR BILIRUBIN Nil
BLOOD Nil Nil
Pseudo-peroxidase
LEUCOCYTE Nil Nil
by an azo-coupling reaction
NITRITE Nil Nil
Diazotization Reaction
MICROSCOPIC EXAMINATION
PUS CELLS 4-6 cells/HPF 0-5
Microscopy
RBCs Nil Cells/HPF Nil
Microscopy
EPITHELIAL CELLS 1-3 Cells/HPF 0-5
Microscopy

Page 12 of 14
Barcode No : 789752 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:12AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 04:52AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : URINE Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF CLINICAL PATHOLOGY

1.2
Test Description Observed Value Unit Reference Range

CRYSTALS ABSENT ABSENT ABSENT

Microscopy
CASTS ABSENT /HPF ABSENT
Microscopy
BACTERIA NIL NIL

Page 13 of 14
Barcode No : 789750 Registration : 13/Apr/2025 12:13AM
Patient Name : MR. BABAR KHAN Received : 13/Apr/2025 04:03AM
Age/Gender : 45 Y 0 M 0 D /M Reported : 13/Apr/2025 06:32AM
Ref Doctor : [Link] Client Name : AB MEDICAL STORE UK
Collected By : [Link] Client Code : UK913
Sample Type : SERUM Client Add : UDHAM SINGH NAGAR UK

DEPARTMENT OF HORMONE ASSAYS

1.2
Test Description Observed Value Unit Reference Range

THYROID PROFILE. (T3,T4,TSH)

TRIODOTHYRONINE TOTAL (T3) 0.95 ng/mL 0.8 - 1.9

CLIA
Summary & Interpretation:.
Triiodothyronine (T3) is the hormone principally responsible for the development of the effects of the thyroid hormones on the various target organsT3 is mainly formed extrathyroidally , particularly in the
liver, by deiodination of T4. A reduction in the conversion of T4 to T3 results in a fall in the T3 [Link] Occurs under the influence of medicaments such as propanolol, glucocorticoids or amiodarone
and in severe non-thyroidal illness (NTI). The determination of T3 is utilized in the diagnosis of T3-hyperthyroidism, the detection of early stages of hyperthyroidism and for indicating a diagnosis of
thyrotoxicosis factitia.

THYROXINE TOTAL (T4) 9.0 ug/dL 5.0 - 13.0

CLIA
Summary & Interpretation:
The hormons thyroxime (T4) is the main product secreted by the thyroid gland. The major part of total thyroxime (T4) in serum is present in protein-bound form. As the concentration of the transport proteins
in serum are subject to exogenous and endogenous effects, the status of the binding proteins must also be taken in to account in the assessment of the thyroid hormone concentration in serum. The
determination of T4 can be utilized for the following indications : the detection of hyperthyroidism, the detection of primary and secondary hypothyroidism and the monitoring of TSH-suppression therapy.

THYROID STIMULATING HORMONE (TSH) 4.285 µIU/mL 0.35 - 4.75

CLIA
Summary & Interpretation
TSH is formed in specific basophil cells of the anterior pituitary and is subject to a circardian secretion [Link] determination of TSH serves as the initial test in thyroid diagnostics,
Accordingly, TSH is a very sensitive and specific parameter for assessing thyroid function and is particularl suitable for early detection or exclusion of disorders in the central regulating circuit
between the hypothalamus, pituitary and thyroid.

Note:
[Link] levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between6-10 pm .The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations
2. Recommended test for T3 and T4 is unbound fraction or free levels as it is metabolically active.
3. Physiological rise in Total T3 / T4 levels is seen in pregnancy and in patients on steroid therapy. 4. Clinical Use: Primary Hypothyroidism, Hyperthyroidism, Hypothalamic –
Pituitary hypothyroidism, Inappropriate TSH secretion, Nonthyroidal illness, Autoimmune thyroid disease, Pregnancy associated thyroid disorders.
PREGNANCY REFERENCE RANGE FOR TSH IN uIU/mL

1st Trimester 0.05 – 3.70

2nd Trimester 0.31 – 4.35

3rd Trimester 0.41– 5.18

*** End Of Report ***

Page 14 of 14